This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Rosenbaum, E Articles by Derk, C. PubMed PubMed Citation Articles by Rosenbaum, E Articles by Derk, C. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Lupus Social Bookmarking                         What's this?

The spectrum of clinical manifestations, outcome and treatment of pericardial tamponade in patients with systemic lupus erythematosus: a retrospective study and literature review

Division of Rheumatology, Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA

E Krebs

Division of Rheumatology, Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA

M Cohen

Division of Rheumatology, Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA

A Tiliakos

Division of Rheumatology, Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA

CT Derk

Division of Rheumatology, Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USAChris.Derk{at}jefferson.edu

Pericardial effusions causing pericardial tamponade are rare in patients with systemic lupus erythematosus (SLE). The goal of this study is to describe in detail the clinical and laboratory characteristics of a group of patients with pericardial effusions and pericardial tamponade secondary to SLE. We retrospectively reviewed the records of 71 patients with SLE, admitted to our Hospital between 1985 and 2006 with a diagnosis of pericarditis, pericardial effusion and tamponade. Clinical features in the patients with tamponade were compared with those with pericardial effusions without tamponade. Pericardial effusion and SLE was confirmed in 41 patients. Pericardial tamponade occurred in nine of these patients (21.9%) at the time of presentation. All tamponade patients were women. Patients with pericardial effusions who developed tamponade had a statistically significant (P = 0.05) lower C4 level as compared with patients who did not develop tamponade. A pericardial window was required in five patients even though the patients were receiving high-dose corticosteroids. In the present series, all patients with tamponade were treated with high-dose corticosteroids though five of nine patients required a pericardial window in contrast to previous studies. A low C4 level at presentation was predictive of the development of tamponade physiology.

Key Words: cardiac manifestations • heart • pericardial effusion • pericarditis • systemic lupus erythematosus • tamponade

Lupus, Vol. 18, No. 7, 608-612 (2009)
DOI: 10.1177/0961203308100659


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?